Cargando…

The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B

Oligomers are commonly observed intermediates at the initial stages of amyloid fibril formation. They are toxic to neurons and cause decrease in neural transmission and long-term potentiation. We describe an in vitro study of the initial steps in amyloid fibril formation by human stefin B, which pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Taler-Verčič, Ajda, Kirsipuu, Tiina, Friedemann, Merlin, Noormägi, Andra, Polajnar, Mira, Smirnova, Julia, Žnidarič, Magda Tušek, Žganec, Matjaž, Škarabot, Miha, Vilfan, Andrej, Staniforth, Rosemary A., Palumaa, Peep, Žerovnik, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794784/
https://www.ncbi.nlm.nih.gov/pubmed/24013380
http://dx.doi.org/10.3390/ijms140918362
_version_ 1782287256450498560
author Taler-Verčič, Ajda
Kirsipuu, Tiina
Friedemann, Merlin
Noormägi, Andra
Polajnar, Mira
Smirnova, Julia
Žnidarič, Magda Tušek
Žganec, Matjaž
Škarabot, Miha
Vilfan, Andrej
Staniforth, Rosemary A.
Palumaa, Peep
Žerovnik, Eva
author_facet Taler-Verčič, Ajda
Kirsipuu, Tiina
Friedemann, Merlin
Noormägi, Andra
Polajnar, Mira
Smirnova, Julia
Žnidarič, Magda Tušek
Žganec, Matjaž
Škarabot, Miha
Vilfan, Andrej
Staniforth, Rosemary A.
Palumaa, Peep
Žerovnik, Eva
author_sort Taler-Verčič, Ajda
collection PubMed
description Oligomers are commonly observed intermediates at the initial stages of amyloid fibril formation. They are toxic to neurons and cause decrease in neural transmission and long-term potentiation. We describe an in vitro study of the initial steps in amyloid fibril formation by human stefin B, which proved to be a good model system. Due to relative stability of the initial oligomers of stefin B, electrospray ionization mass spectrometry (ESI MS) could be applied in addition to size exclusion chromatography (SEC). These two techniques enabled us to separate and detect distinguished oligomers from the monomers: dimers, trimers, tetramers, up to decamers. The amyloid fibril formation process was followed at different pH and temperatures, including such conditions where the process was slow enough to detect the initial oligomeric species at the very beginning of the lag phase and those at the end of the lag phase. Taking into account the results of the lower-order oligomers transformations early in the process, we were able to propose an improved model for the stefin B fibril formation.
format Online
Article
Text
id pubmed-3794784
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-37947842013-10-21 The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B Taler-Verčič, Ajda Kirsipuu, Tiina Friedemann, Merlin Noormägi, Andra Polajnar, Mira Smirnova, Julia Žnidarič, Magda Tušek Žganec, Matjaž Škarabot, Miha Vilfan, Andrej Staniforth, Rosemary A. Palumaa, Peep Žerovnik, Eva Int J Mol Sci Article Oligomers are commonly observed intermediates at the initial stages of amyloid fibril formation. They are toxic to neurons and cause decrease in neural transmission and long-term potentiation. We describe an in vitro study of the initial steps in amyloid fibril formation by human stefin B, which proved to be a good model system. Due to relative stability of the initial oligomers of stefin B, electrospray ionization mass spectrometry (ESI MS) could be applied in addition to size exclusion chromatography (SEC). These two techniques enabled us to separate and detect distinguished oligomers from the monomers: dimers, trimers, tetramers, up to decamers. The amyloid fibril formation process was followed at different pH and temperatures, including such conditions where the process was slow enough to detect the initial oligomeric species at the very beginning of the lag phase and those at the end of the lag phase. Taking into account the results of the lower-order oligomers transformations early in the process, we were able to propose an improved model for the stefin B fibril formation. MDPI 2013-09-05 /pmc/articles/PMC3794784/ /pubmed/24013380 http://dx.doi.org/10.3390/ijms140918362 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland http://creativecommons.org/licenses/by/3.0 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Taler-Verčič, Ajda
Kirsipuu, Tiina
Friedemann, Merlin
Noormägi, Andra
Polajnar, Mira
Smirnova, Julia
Žnidarič, Magda Tušek
Žganec, Matjaž
Škarabot, Miha
Vilfan, Andrej
Staniforth, Rosemary A.
Palumaa, Peep
Žerovnik, Eva
The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B
title The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B
title_full The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B
title_fullStr The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B
title_full_unstemmed The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B
title_short The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B
title_sort role of initial oligomers in amyloid fibril formation by human stefin b
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794784/
https://www.ncbi.nlm.nih.gov/pubmed/24013380
http://dx.doi.org/10.3390/ijms140918362
work_keys_str_mv AT talervercicajda theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT kirsipuutiina theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT friedemannmerlin theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT noormagiandra theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT polajnarmira theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT smirnovajulia theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT znidaricmagdatusek theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT zganecmatjaz theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT skarabotmiha theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT vilfanandrej theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT staniforthrosemarya theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT palumaapeep theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT zerovnikeva theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT talervercicajda roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT kirsipuutiina roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT friedemannmerlin roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT noormagiandra roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT polajnarmira roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT smirnovajulia roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT znidaricmagdatusek roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT zganecmatjaz roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT skarabotmiha roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT vilfanandrej roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT staniforthrosemarya roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT palumaapeep roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb
AT zerovnikeva roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb